Acute Management of Asthma Exacerbation
All patients with asthma exacerbation should immediately receive three treatments: supplemental oxygen to maintain SpO2 >90% (>95% in pregnancy/cardiac disease), inhaled short-acting beta-2 agonists (albuterol) given 3 times every 20 minutes in the first hour, and oral corticosteroids (prednisone) for moderate-to-severe exacerbations or those not responding to initial bronchodilator therapy 1.
Initial Assessment and Oxygen
Start oxygen immediately via nasal cannula or mask targeting:
- SpO2 >90% in most patients
- SpO2 >95% in pregnant women and those with heart disease
- Continue monitoring until clear response to bronchodilators occurs 1
Bronchodilator Therapy
First-Line: Short-Acting Beta-2 Agonists
Administer albuterol repetitively—this is the most effective means of reversing airflow obstruction 1:
- Initial dosing: 3 treatments every 20-30 minutes in the first hour
- Mild exacerbations: 4-12 puffs via MDI with spacer (if patient can cooperate)
- Moderate-to-severe: Nebulizer therapy preferred, especially if patient agitated or unable to use MDI effectively
- Severe exacerbations (FEV1 or PEF <40% predicted): Consider continuous nebulization rather than intermittent dosing 1
Approximately 60-70% of patients respond sufficiently to these initial 3 doses for discharge consideration 1.
Add Ipratropium Bromide for Severe Cases
For severe exacerbations, add ipratropium (short-acting muscarinic antagonist) to beta-agonist therapy—this combination reduces hospitalizations 1, 2. The addition of anticholinergic therapy is particularly important when patients don't rapidly respond to beta-agonists alone 3.
Systemic Corticosteroids
Give oral prednisone to all patients with moderate-to-severe exacerbations and those not responding to initial beta-agonist therapy 1:
- Route: Oral prednisone is equivalent to IV methylprednisolone but less invasive—use oral unless patient cannot tolerate 1
- Timing: Early administration reduces hospitalization likelihood 1
- Special consideration: Give supplemental doses even for mild exacerbations if patient regularly takes corticosteroids 1
The evidence does not support high-dose inhaled corticosteroids over oral corticosteroids in acute settings 1.
Adjunctive Therapies for Severe Exacerbations
Magnesium Sulfate
For severe exacerbations, administer IV magnesium sulfate—this has been associated with fewer hospitalizations 2, 4. Current evidence favors IV over nebulized magnesium 4.
Heliox (Helium-Oxygen Mixture)
Consider in patients not responding to standard therapies or those with severe disease 4.
Critical Pitfalls to Avoid
- Don't delay corticosteroids: Waiting to see if bronchodilators alone work increases hospitalization risk
- Don't use only intermittent bronchodilators in severe cases: Continuous nebulization is more effective when FEV1/PEF <40% predicted 1
- Don't use high-dose non-selective beta-agonists: Stick to selective agents (albuterol, levalbuterol, pirbuterol) to avoid cardiotoxicity 1
- Don't forget oxygen monitoring: Continue until clear bronchodilator response occurs 1
Disposition Criteria
Discharge is appropriate when patients show improvement in symptoms AND FEV1 or PEF reaches 60-80% of predicted values 2. Most patients responding to initial therapy (60-70%) demonstrate significant improvement after the first dose 1.
Pre-Hospital/EMS Management
EMS should administer oxygen and inhaled bronchodilators without delaying transport, with maximum 3 treatments in first hour, then 1 per hour 1. If beta-agonist unavailable, subcutaneous epinephrine or terbutaline can be used for severe cases 1.